产品名称 | NebuSelect™ Recombinant Mouse CLEC10A, His-tag |
---|---|
目录号 | NBL-240878 |
别名 | CLEC10A; CD301; CLEC10A; CLECSF13; CLECSF14; HML; HML2; MGL |
外观 | see COA |
分子量 | Gln57-Ser304 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | P49300 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-240878-100ug | 100ug | Inquire | Inquire | |
NBL-240878-1mg | 1mg | Inquire | Inquire | |
NBL-240878-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Mouse CLEC10A, His-tag
Catalog#:
NBL-240878
Description:
NebuSelect™ Recombinant Mouse CLEC10A, His-tag(Cat#NBL-240878) is expressed in HEK293 with His tag at the C-Terminus.It contains Gln57-Ser304.
Species:
Mouse
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 29.4 kDa. Due to glycosylation, the protein migrates to 38-45 kDa based on Bis-Tris PAGE result.
Target Name:
CLEC10A; CD301; CLEC10A; CLECSF13; CLECSF14; HML; HML2; MGL
Target Information:
CLEC10A, (C-type lectin domain family 10, member A), as the member of C-type lectin receptors (CLRs), plays a vital role in modulating innate immunity and adaptive immunity and has shown great potential as an immunotherapy target for cancers. However, there is no functional research of CLEC10A in prognostic risk, immunotherapy or any other treatment of lung adenocarcinoma (LUAD).
Amino Acid Sequence:
Gln57-Ser304
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.